surpass tirzepatide Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial tirzepatide and type 2 diabetes

Injections, oral capsules, or transdermal creams make up the most frequently used forms of peptide therapy

Less common side effects of Wegovy There are also some less common side effects which occur in less than 10% of people who take Wegovy that may happen due to the effect the medication has on your body

Typical use concentrations range from 0.3-1% depending on the formula, and this ingredient is capped at 1% int the EU

Gallbladder Disease and Surgical Complications Novo Nordisk added gallbladder disease warnings to Ozempic labels in March 2022, but only after thousands of patients had already developed acute cholecystitis, gallstones, and other biliary complications requiring emergency surgery raising questions about what the company knew and when